dc.contributor.author
Schneider-Schaulies, Sibylle
dc.contributor.author
Schumacher, Fabian
dc.contributor.author
Wigger, Dominik
dc.contributor.author
Schöl, Marie
dc.contributor.author
Waghmare, Trushnal
dc.contributor.author
Schlegel, Jan
dc.contributor.author
Seibel, Jürgen
dc.contributor.author
Kleuser, Burkhard
dc.date.accessioned
2021-12-16T14:18:39Z
dc.date.available
2021-12-16T14:18:39Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/33175
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-32897
dc.description.abstract
As viruses are obligatory intracellular parasites, any step during their life cycle strictly depends on successful interaction with their particular host cells. In particular, their interaction with cellular membranes is of crucial importance for most steps in the viral replication cycle. Such interactions are initiated by uptake of viral particles and subsequent trafficking to intracellular compartments to access their replication compartments which provide a spatially confined environment concentrating viral and cellular components, and subsequently, employ cellular membranes for assembly and exit of viral progeny. The ability of viruses to actively modulate lipid composition such as sphingolipids (SLs) is essential for successful completion of the viral life cycle. In addition to their structural and biophysical properties of cellular membranes, some sphingolipid (SL) species are bioactive and as such, take part in cellular signaling processes involved in regulating viral replication. It is especially due to the progress made in tools to study accumulation and dynamics of SLs, which visualize their compartmentalization and identify interaction partners at a cellular level, as well as the availability of genetic knockout systems, that the role of particular SL species in the viral replication process can be analyzed and, most importantly, be explored as targets for therapeutic intervention.
en
dc.format.extent
21 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
glycosphingolipids
en
dc.subject
sphingosine 1-phosphate
en
dc.subject
sphingomyelinase
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik
dc.title
Sphingolipids: Effectors and Achilles Heals in Viral Infections?
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
2175
dcterms.bibliographicCitation.doi
10.3390/cells10092175
dcterms.bibliographicCitation.journaltitle
Cells
dcterms.bibliographicCitation.number
9
dcterms.bibliographicCitation.originalpublishername
MDPI
dcterms.bibliographicCitation.volume
10
dcterms.bibliographicCitation.url
https://doi.org/10.3390/cells10092175
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie
refubium.note.author
Die Publikation wurde aus Open Access Publikationsgeldern der Freien Universität Berlin gefördert.
de
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2073-4409